These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 19178384)

  • 1. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
    Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
    Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the function of relaxins.
    Rosengren KJ; Bathgate RA; Craik DJ; Daly NL; Haugaard-Jönsson LM; Hossain MA; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():20-6. PubMed ID: 19416153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural properties of relaxin chimeras.
    Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
    Ann N Y Acad Sci; 2009 Apr; 1160():27-30. PubMed ID: 19416154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
    Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
    Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional solution structure of bombyxin-II an insulin-like peptide of the silkmoth Bombyx mori: structural comparison with insulin and relaxin.
    Nagata K; Hatanaka H; Kohda D; Kataoka H; Nagasawa H; Isogai A; Ishizaki H; Suzuki A; Inagaki F
    J Mol Biol; 1995 Nov; 253(5):749-58. PubMed ID: 7473749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of relaxin properties into other hormones of insulin-like structure.
    Büllesbach EE; Schwabe C
    SAAS Bull Biochem Biotechnol; 1996; 9():63-8. PubMed ID: 8652134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and activity in the relaxin family of peptides.
    Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of allosteric ligand-receptor interactions in the insulin/relaxin peptide family: implications for other receptor tyrosine kinases and G-protein-coupled receptors.
    De Meyts P; Gauguin L; Svendsen AM; Sarhan M; Knudsen L; Nøhr J; Kiselyov VV
    Ann N Y Acad Sci; 2009 Apr; 1160():45-53. PubMed ID: 19416158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation.
    Belgi A; Hossain MA; Shabanpoor F; Chan L; Zhang S; Bathgate RA; Tregear GW; Wade JD
    Biochemistry; 2011 Oct; 50(39):8352-61. PubMed ID: 21866895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants.
    Eigenbrot C; Randal M; Quan C; Burnier J; O'Connell L; Rinderknecht E; Kossiakoff AA
    J Mol Biol; 1991 Sep; 221(1):15-21. PubMed ID: 1656049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
    Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity.
    Patil NA; Bathgate RAD; Kocan M; Ang SY; Tailhades J; Separovic F; Summers R; Grosse J; Hughes RA; Wade JD; Hossain MA
    Amino Acids; 2016 Apr; 48(4):987-992. PubMed ID: 26661035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coevolution of the relaxin-like peptides and their receptors.
    Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor.
    Ward CW; Lawrence MC
    Bioessays; 2009 Apr; 31(4):422-34. PubMed ID: 19274663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8.
    Lin F; Otvos L; Kumagai J; Tregear GW; Bathgate RA; Wade JD
    J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
    Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD
    Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
    Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
    Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.